DataMeds AI, Inc.
Tampa, Florida, United States · Artificial Intelligence, Biotechnology, Health Care
Wellgistics Health, Inc. is a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment. The firm focuses on advancing healthcare technology and solutions for independent pharmacists. With a recent management upgrade, Wellgistics aims to become a force in blockchain-enabled medication tracking. They are enhancing their capabilities to meet
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Tampa, Florida, United States
- Employees
- Unknown
- Industries
- Artificial Intelligence, Biotechnology, Health Care
- Status
- Public (MEDS)
- Website
- datamedsai.com
Recent activity at DataMeds AI, Inc.
- : SEC 8-K (1.02): On November 3, 2026, DataMEDS AI, Inc. terminated its Second Amended and Restated Letter of Intent (LOI) that was originally established on October 21, 2026, with multiple parties including EOS Technology Holdings, Inc., Scilex Holding Company, and Datavault AI Inc. The LOI had outlined plans for the acquisition of intellectual property assets and expansions involving several affiliated companies in exchange for shares of DataMEDS' common stock. The termination is immediate and does not affect existing agreements with Datavault or any other arrangements. This decision indicates a strategic shift for DataMEDS AI as it moves away from the proposed transactions with these partners.
- : DataMEDS AI, Inc. to Acquire Key Health Technology Assets
- : SEC 8-K (1.01): On October 21, 2026, DataMEDS AI, Inc. entered into a non-binding Second Amended and Restated Letter of Intent (LOI) with multiple parties including EOS Technology Holdings, Inc., Scilex Holding Company, Datavault AI Inc., HealthBridge Advisors, LLC, Tollo Health, Inc., and REBOOT Health AI, Inc. This arrangement includes the acquisition of Quality of Life Peace of Mind intellectual property assets from EOS and Scilex, the expansion of an existing PharmacyChain license with Datavault, and a controlling interest in Health Lives Here through an exchange of membership interests. The transaction is expected to result in those parties collectively owning approximately 89.5% of the Company's common stock. The effective date of the arrangements discussed is within the past 3 days, making it a timely significant business agreement.
About DataMeds AI, Inc.: questions and answers
What does DataMeds AI, Inc. do?
Wellgistics Health, Inc. is a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment. The firm focuses on advancing healthcare technology and solutions for independent pharmacists. With a recent management upgrade, Wellgistics aims to become a force in blockchain-enabled medication tracking. They are enhancing their capabilities to meet
Where is DataMeds AI, Inc. headquartered?
DataMeds AI, Inc. is headquartered in Tampa, Florida, United States.
What is the latest news on DataMeds AI, Inc.?
On Nov 05, 2026, SEC 8-K (1.02): On November 3, 2026, DataMEDS AI, Inc. terminated its Second Amended and Restated Letter of Intent (LOI) that was originally established on October 21, 2026, with multiple parties including EOS Technology Holdings, Inc., Scilex Holding Company, and Datavault AI Inc. The LOI had outli
Is DataMeds AI, Inc. a public company?
Yes. DataMeds AI, Inc. is publicly traded under the ticker MEDS.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy